+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Flow Cytometry Market Size, Share & Trends Analysis Report By Product & Services, By Technology (Cell-based, Bead-based), By Application (Research, Industrial, Clinical), By End Use, By Region, And Segment Forecasts, 2019 - 2026

  • ID: 4118843
  • Report
  • June 2019
  • Region: Global
  • 100 pages
  • Grand View Research
1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Agilent Technologies
  • Apogee Flow Systems
  • Beckman Coulter
  • Bio-Rad Laboratories
  • EMD Millipore Corp
  • GE Healthcare
  • MORE
The global flow cytometry market size is expected to reach USD 8.92 billion by 2026 registering a CAGR of 10.6%, according to this report. Increasing incidence of infectious diseases and cancer is expected to upsurge the demand for flow cytometers for disease diagnosis. In addition, rising usage of autologous and allogenic stem cell therapy by physicians, due to adverse effects of radiation and chemotherapy in the treatment of cancer, will also drive the market.

High demand for Point-of-Care (PoC) testing in chronic disease management is also expected to fuel the demand for cytometry techniques. Increasing R&D initiatives by key companies for the development of multicolor assays and advanced reagents for analysis are anticipated to boost the demand further. Furthermore, technological advancements, in terms of enhanced accuracy, portability, and cost-effectiveness, are expected to offer lucrative growth opportunities for the market.

Small-size high-throughput cytometers are expected to gain popularity over the coming years as they are cost-effective and easy to use. Furthermore, improvement in fluorescent dyes and introduction of bench top cytometers are the other growth propellers. For instance, multicolor flow cytometry coupled with multiple lasers is the fastest-growing application segment, which finds extensive applications in the field of R&D innovations in new drug development and is adopted by many Contract Research Organizations (CRO).

Further key findings from the study suggest:
  • Bead-based flow cytometry is anticipated to witness the highest CAGR over the forecast period owing to increasing advancements in molecular engineering and monoclonal antibody production
  • Reagent & consumable is anticipated to be the fastest-growing product & services segment from 2019 to 2026 due to extensive utilization in molecular diagnostics
  • Commercial organizations segment held the largest revenue share due to large-scale production of proteins, cell line development, and other biologicals coupled with high demand for cell sorting and analysis techniques
  • Asia Pacific regional is presumed to witness the fastest CAGR from 2019 to 2025 owing to supportive government initiatives for the development of biotech industry and growing awareness about the applications of flow cytometers
  • Multinational companies are collaborating with local diagnostic companies and healthcare institutions in developing countries to strengthen their position in the global flow cytometry market

Please note: This product will be delivered within 48 business hours after receipt of order.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Agilent Technologies
  • Apogee Flow Systems
  • Beckman Coulter
  • Bio-Rad Laboratories
  • EMD Millipore Corp
  • GE Healthcare
  • MORE
Chapter 1 Research Methodology & Scope
1.1 Market Segmentation and Scope
1.1.1 Products & Services
1.1.2 Technology
1.1.3 Application
1.1.4 End Use
1.1.5 Regional Scope
1.1.6 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database:
1.3.2 Internal database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.3.5.1 Data For Primary Interviews In North America
1.3.5.2 Data For Primary Interviews In Europe
1.3.5.3 Data For Primary Interviews In Asia Pacific
1.3.5.4 Data For Primary Interviews In Middle East And Africa
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.2 Volume Price Analysis (Model 2)
1.6.2.1 Approach 2: Volume Price Analysis
1.7 List Of Secondary Sources
1.8 List Of Primary Sources
1.9 List Of Abbreviations
1.10 Objectives
1.10.1 Objective 1
1.10.2 Objective 2
1.10.3 Objective 3
1.10.4 Objective 4

Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights

Chapter 3 Flow Cytometry Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Penetration & Growth Prospect Mapping
3.3 User Perspective Analysis
3.3.1 Consumer Behavior Analysis
3.3.2 Market Influencer Analysis
3.4 List Of Key End Users
3.5 Regulatory Framework
3.6 Market Dynamics
3.6.1 Market Driver Analysis
3.6.1.1 Growing Prevalence Of Target Disorders
3.6.1.2 Increasing Demand For In Vitro Diagnostics
3.6.1.3 Growing R & D Investments In Biotechnology Sector
3.6.1.4 Technological Advancements
3.6.1.5 Increasing Demand For Point Of Care Diagnostics
3.6.2 Market Restraint Analysis
3.6.2.1 High Cost Of Instruments
3.7 Flow Cytometry - Swot Analysis By Factors, (Political & Legal, Economical, Technological)
3.8 Market Analysis Tools
3.8.1 Industry Analysis - Porter’s
3.8.1.1 Bargaining Power Of Buyers:
3.8.1.2 Bargaining Power Of Suppliers:
3.8.1.3 Competitive Rivalry:
3.8.1.4 Threat Of New Entrants:
3.8.1.5 Threat Of Substitutes:
3.8.2 Pestle Analysis
3.8.2.1 Political Landscape
3.8.2.2 Environmental Landscape
3.8.2.3 Social Landscape
3.8.2.4 Technology Landscape
3.8.2.5 Legal Landscape
3.8.2.6 Economic Landscape
3.8.3 Major Deals And Strategic Alliances
3.8.3.1 New Product Launch
3.8.3.2 Acquisition
3.8.3.3 Partnerships
3.8.3.4 Marketing & Promotions
3.8.3.5 Market Entry Strategies

Chapter 4 Flow Cytometry Market: Technology Estimates & Trend Analysis
4.1 Definition And Scope
4.2 Flow Cytometry Market: Technology Movement Analysis
4.3 Segment Dashboard
4.4 Global Flow Cytometry Market, By Technology, 2015 To 2026
4.5 Market Size & Forecasts And Trend Analyses, 2015 To 2026
4.5.1 Cell Based
4.5.1.1 Cell Based Market, 2014 - 2026 (USD Million)
4.5.2 Bead Based
4.5.2.1 Bead Based Market, 2014 - 2026 (USD Million)

Chapter 5 Flow Cytometry Market: Product & Services Estimates & Trend Analysis
5.1 Definition And Scope
5.2 Flow Cytometry Market: Product & Services Movement Analysis
5.3 Segment Dashboard
5.4 Global Flow Cytometry Market, By Product, 2015 To 2026
5.5 Market Size & Forecasts And Trend Analyses, 2015 To 2026
5.5.1 Instruments
5.5.1.1 Instruments Market, 2014 - 2026 (USD Million)
5.5.2 Reagents & Consumables
5.5.2.1 Reagents & Consumables Market, 2014 - 2026 (USD Million)
5.5.3 Software
5.5.3.1 Software Market, 2014 - 2026 (USD Million)
5.5.4 Accessories
5.5.4.1 Accessories Market, 2014 - 2026 (USD Million)
5.5.5 Services
5.5.5.1 Services Market, 2014 - 2026 (USD Million)

Chapter 6 Flow Cytometry Market: Application Estimates & Trend Analysis
6.1 Definition And Scope
6.2 Flow Cytometry Market: Applications Movement Analysis
6.3 Segment Dashboard
6.4 Global Flow Cytometry Market, By Product, 2015 To 2026
6.5 Market Size & Forecasts And Trend Analyses, 2015 To 2026
6.5.1 Research
6.5.1.1 Research Market, 2014 - 2026 (USD Million)
6.5.1.2 Pharmaceutical
6.5.1.2.1 Pharmaceutical Market, 2014 - 2026 (USD Million)
6.5.1.3 Apoptosis
6.5.1.3.1 Apoptosis Market, 2014 - 2026 (USD Million)
6.5.1.4 Cell Sorting
6.5.1.4.1 Cell Sorting Market, 2014 - 2026 (USD Million)
6.5.1.5 Cell Cycle Analysis
6.5.1.5.1 Cell Cycle Analysis Market, 2014 - 2026 (USD Million)
6.5.1.6 Immunology
6.5.1.6.1 Immunology Market, 2014 - 2026 (USD Million)
6.5.1.7 Cell Viability
6.5.1.7.1 Cell Viability Market, 2014 - 2026 (USD Million)
6.5.2 Industrial
6.5.2.1 Industrial Market, 2014 - 2026 (USD Million)
6.5.3 Clinical
6.5.3.1 Clinical Market, 2014 - 2026 (USD Million)
6.5.3.1.1 Cancer
6.5.3.1.2 Organ Transplantation
6.5.3.1.3 Immunodeficiency
6.5.3.1.4 Haematology

Chapter 7 Flow Cytometer Market: End-Use Estimates & Trend Analysis
7.1 Definition And Scope
7.2 Flow Cytometry Market: End-Use Movement Analysis
7.3 Segment Dashboard
7.4 Global Flow Cytometry Market, By Product, 2015 To 2026
7.5 Market Size & Forecasts And Trend Analyses, 2015 To 2026
7.5.1 Commercial Organizations
7.5.1.1 Commercial Organizations Market, 2014 - 2026 (USD Million)
7.5.2 Hospitals
7.5.2.1 Hospitals Market, 2014 - 2026 (USD Million)
7.5.3 Academic Institutes
7.5.3.1 Academic Institutes Market, 2014 - 2026 (USD Million)
7.5.4 Clinical Testing Labs
7.5.4.1 Clinical Testing Labs Market, 2014 - 2026 (USD Million)

Chapter 8 Flow Cytometry Market: Regional Estimates & Trend Analysis, By Technology, Product & Services, Application, And End-Use
8.1 Definition & Scope
8.2 Flow Cytometry Market Share By Region, 2016 & 2025
8.3 Regional Dashboard
8.4 Regional Market Share And Leading Players, 2018
8.4.1 North America
8.4.2 Europe
8.4.3 Asia Pacific
8.4.4 Latin America
8.4.5 Middle East And Africa
8.5 Market Size, & Forecasts, Volume And Trend Analysis, 2018 To 2025
8.6 North America
8.6.1 North America Flow Cytometry Market, 2014 - 2026 (USD Million)
8.6.2 U.S.
8.6.2.1 U.S. Flow Cytometry Market, 2014 - 2026 (USD Million)
8.6.3 Canada
8.6.3.1 Canada Flow Cytometry Market, 2014 - 2026 (USD Million)
8.7 Europe
8.7.1 Europe Flow Cytometry Market, 2014 - 2026 (USD Million)
8.7.2 U.K.
8.7.2.1 U.K. Flow Cytometry Market, 2014 - 2026 (USD Million)
8.7.3 Germany
8.7.3.1 Germany Flow Cytometry Market, 2014 - 2026 (USD Million)
8.7.4 France
8.7.4.1 France Flow Cytometry Market, 2014 - 2026 (USD Million)
8.7.5 Italy
8.7.5.1 Italy Flow Cytometry Market, 2014 - 2026 (USD Million)
8.7.6 Spain
8.7.6.1 Spain Flow Cytometry Market, 2014 - 2026 (USD Million)
8.7.7 Russia
8.7.7.1 Russia Flow Cytometry Market, 2014 - 2026 (USD Million)
8.8 Asia Pacific
8.8.1 Asia Pacific Flow Cytometry Market, 2014 - 2026 (USD Million)
8.8.2 Japan
8.8.2.1 Japan Flow Cytometry Market, 2014 - 2026 (USD Million)
8.8.3 China
8.8.3.1 China Flow Cytometry Market, 2014 - 2026 (USD Million)
8.8.4 India
8.8.4.1 India Flow Cytometry Market, 2014 - 2026 (USD Million)
8.8.5 Australia
8.8.5.1 Australia Flow Cytometry Market, 2014 - 2026 (USD Million)
8.8.6 South Korea
8.8.6.1 South Korea Flow Cytometry Market, 2014 - 2026 (USD Million)
8.8.7 Singapore
8.8.7.1 Singapore Flow Cytometry Market, 2014 - 2026 (USD Million)
8.9 Latin America
8.9.1 Latin America Flow Cytometry Market, 2014 - 2026 (USD Million)
8.9.2 Brazil
8.9.2.1 Brazil Flow Cytometry Market, 2014 - 2026 (USD Million)
8.9.3 Mexico
8.9.3.1 Mexico Flow Cytometry Market, 2014 - 2026 (USD Million)
8.9.4 Argentina
8.9.4.1 Argentina Flow Cytometry Market, 2014 - 2026 (USD Million)
8.10 Mea
8.10.1 Mea Flow Cytometry Market, 2014 - 2026 (USD Million)
8.10.2 South Africa
8.10.2.1 South Africa Flow Cytometry Market, 2014 - 2026 (USD Million)
8.10.3 Saudi Arabia
8.10.3.1 Saudi Arabia Flow Cytometry Market, 2014 - 2026 (USD Million)
8.10.4 Uae
8.10.4.1 Uae Flow Cytometry Market, 2014 - 2026 (USD Million)
8.10.5 Iran
8.10.5.1 Iran Flow Cytometry Market, 2014 - 2026 (USD Million)
8.10.6 Turkey
8.10.6.1 Turkey Flow Cytometry Market, 2014 - 2026 (USD Million)

Chapter 9 Competitive Landscape
9.1 Company Profiles
9.1.1 Beckman Coulter
9.1.1.1 Company overview
9.1.1.2 Financial performance
9.1.1.3 Product benchmarking
9.1.1.4 Strategic initiatives
9.1.2 Becton, Dickinson and Company
9.1.2.1 Company overview
9.1.2.2 Financial performance
9.1.2.3 Product benchmarking
9.1.2.4 Strategic initiatives
9.1.3 Sysmex Corporation
9.1.3.1 Company Overview
9.1.3.2 Financial performance
9.1.3.3 Product benchmarking
9.1.3.4 Strategic initiatives
9.1.4 Agilent Technologies
9.1.4.1 Company overview
9.1.4.2 Financial performance
9.1.4.3 Product benchmarking
9.1.4.4 Strategic initiatives
9.1.5 EMD Millipore Corp
9.1.5.1 Company overview
9.1.5.2 Financial performance
9.1.5.3 Product benchmarking
9.1.5.4 Strategic initiatives
9.1.6 Apogee Flow Systems
9.1.6.1 Company overview
9.1.6.2 Product benchmarking
9.1.7 Bio-Rad Laboratories
9.1.7.1 Company overview
9.1.7.2 Financial performance
9.1.7.3 Product benchmarking
9.1.7.4 Strategic initiatives
9.1.8 Life Technologies Corporation
9.1.8.1 Company overview
9.1.8.2 Financial performance
9.1.8.3 Product benchmarking
9.1.8.4 Strategic initiatives
9.1.9 Stratedigm
9.1.9.1 Company overview
9.1.9.2 Product benchmarking
9.1.10 Luminex Corporation
9.1.10.1 Company overview
9.1.10.2 Financial performance
9.1.10.3 Product benchmarking
9.1.10.4 Strategic initiatives
9.1.11 MiltenyiBiotec
9.1.11.1 Company overview
9.1.11.2 Product benchmarking
9.1.11.3 Strategic initiatives
9.1.12 GE Healthcare
9.1.12.1 Company overview
9.1.12.2 Financial performance
9.1.12.3 Product benchmarking
9.1.12.4 Strategic initiatives
Note: Product cover images may vary from those shown
3 of 4
  • Beckman Coulter
  • Becton, Dickinson and Company
  • Sysmex Corporation
  • Agilent Technologies
  • EMD Millipore Corp
  • Apogee Flow Systems
  • Bio-Rad Laboratories
  • Life Technologies Corporation
  • Stratedigm
  • Luminex Corporation
  • MiltenyiBiotec
  • GE Healthcare
Note: Product cover images may vary from those shown
4 of 4

Loading
LOADING...

Adroll
adroll